Particle.news

Ebola Outbreak in Eastern Congo Grows Rapidly as WHO Elevates Risk

The rare Bundibugyo strain is driving a fast‑spreading epidemic that has no approved vaccine or treatment and has forced WHO to push experimental drugs and accelerate vaccine work.

Overview

  • Health authorities say the outbreak has expanded to roughly 82 confirmed cases and about 746–750 suspected cases with 160–177 suspected deaths, a surge that WHO described as still spreading rapidly after its May 22 updates.
  • Tests and surveillance initially missed the Bundibugyo species, a rarely seen Ebola type for which standard rapid diagnostics and licensed countermeasures do not exist, allowing the virus to circulate undetected for weeks.
  • WHO declared the event a public health emergency of international concern and raised the national risk level to very high while prioritizing two monoclonal antibodies and the antiviral obeldesivir for clinical evaluation.
  • Response teams are struggling to contain transmission because contact tracing and testing lag behind infections; ministry data showed follow-up with only about 20–21% of identified contacts on a given day.
  • Local authorities have banned wakes and limited gatherings, neighbouring countries have tightened border and screening rules, and researchers at Oxford and others are racing to develop and test a Bundibugyo vaccine, a process that could take months.